Literature DB >> 17169536

Screening for differences in the amorphous state of indomethacin using multivariate visualization.

Marja Savolainen1, Andrea Heinz, Clare Strachan, Keith C Gordon, Jouko Yliruusi, Thomas Rades, Niklas Sandler.   

Abstract

The aim of this study was to examine molecular-level differences in the amorphous state of indomethacin prepared from both alpha- and gamma-polymorphs using various preparative techniques: milling, quench cooling of a melt, slow cooling of a melt and spray drying. X-ray powder diffraction (XRPD), polarizing light microscopy (PLM), differential scanning calorimetry, as well as mid-infrared (MIR), near infrared (NIR) and Raman spectroscopy were used to analyze the samples after preparation. Principal component analysis (PCA) was used to visualize the differences in the spectroscopic data. According to the XRPD and PLM measurements, all samples except the spray dried indomethacin were amorphous after preparation. Spray dried indomethacin had some remaining residual crystallinity. Differences in the amorphous samples could be found on molecular level: the milled samples clustered separately from the other amorphous samples in the PCA of MIR, NIR and Raman spectra. This could be due to either small degrees of undetected crystallinity remaining in the samples after milling or differences in the hydrogen bonding in the different amorphous samples of indomethacin. The spectroscopic techniques revealed different information about the samples. Raman spectroscopy was most sensitive to differences caused by the preparation techniques and degradation products. Multivariate methods, such as PCA, offer an efficient tool to screen for these differences in the amorphous state.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169536     DOI: 10.1016/j.ejps.2006.10.010

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  14 in total

1.  Fast surface crystallization of amorphous griseofulvin below T g.

Authors:  Lei Zhu; Janan Jona; Karthik Nagapudi; Tian Wu
Journal:  Pharm Res       Date:  2010-04-23       Impact factor: 4.200

2.  Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit e100.

Authors:  Sandrien Janssens; Ann De Zeure; Amrit Paudel; Jan Van Humbeeck; Patrick Rombaut; Guy Van den Mooter
Journal:  Pharm Res       Date:  2010-03-02       Impact factor: 4.200

3.  Intact nanoparticulate indomethacin in fast-dissolving carrier particles by combined wet milling and aerosol flow reactor methods.

Authors:  Timo Laaksonen; Peng Liu; Antti Rahikkala; Leena Peltonen; Esko I Kauppinen; Jouni Hirvonen; Kristiina Järvinen; Janne Raula
Journal:  Pharm Res       Date:  2011-05-04       Impact factor: 4.200

4.  Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.

Authors:  E Kaminska; K Adrjanowicz; D Zakowiecki; B Milanowski; M Tarnacka; L Hawelek; M Dulski; J Pilch; W Smolka; I Kaczmarczyk-Sedlak; K Kaminski
Journal:  Pharm Res       Date:  2014-05-15       Impact factor: 4.200

5.  Effect of processing route on the surface properties of amorphous indomethacin measured by inverse gas chromatography.

Authors:  D J Burnett; J Khoo; M Naderi; J Y Y Heng; G D Wang; F Thielmann
Journal:  AAPS PharmSciTech       Date:  2012-11-08       Impact factor: 3.246

6.  Image-based dissolution analysis for tracking the surface stability of amorphous powders.

Authors:  Jernej Štukelj; Mikael Agopov; Jouko Yliruusi; Clare J Strachan; Sami Svanbäck
Journal:  ADMET DMPK       Date:  2020-07-13

7.  Quantification of Process Induced Disorder in Milled Samples Using Different Analytical Techniques.

Authors:  Ulrike Zimper; Jaakko Aaltonen; Cushla M McGoverin; Keith C Gordon; Karen Krauel-Goellner; Thomas Rades
Journal:  Pharmaceutics       Date:  2010-02-16       Impact factor: 6.321

8.  The influence of pressure on the intrinsic dissolution rate of amorphous indomethacin.

Authors:  Korbinian Löbmann; Konstantina Flouda; Danwen Qiu; Theodosia Tsolakou; Wenbo Wang; Thomas Rades
Journal:  Pharmaceutics       Date:  2014-08-20       Impact factor: 6.321

9.  Fluorescence-suppressed time-resolved Raman spectroscopy of pharmaceuticals using complementary metal-oxide semiconductor (CMOS) single-photon avalanche diode (SPAD) detector.

Authors:  Tatu Rojalin; Lauri Kurki; Timo Laaksonen; Tapani Viitala; Juha Kostamovaara; Keith C Gordon; Leonardo Galvis; Sebastian Wachsmann-Hogiu; Clare J Strachan; Marjo Yliperttula
Journal:  Anal Bioanal Chem       Date:  2015-11-09       Impact factor: 4.142

10.  Crystallization Kinetics of an Amorphous Pharmaceutical Compound Using Fluorescence-Lifetime-Imaging Microscopy.

Authors:  Kaisa Rautaniemi; Elina Vuorimaa-Laukkanen; Clare J Strachan; Timo Laaksonen
Journal:  Mol Pharm       Date:  2018-04-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.